Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS
PHASE4CompletedINTERVENTIONAL
Enrollment
33
Participants
Timeline
Start Date
July 31, 2013
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Conditions
Multiple SclerosisAutonomic Nervous System Dysfunction
Interventions
DRUG
Gilenya
Autonomic testing during first dose administration of Gilenya.
Trial Locations (1)
9000
Cantonal Hospital St. Gallen, Sankt Gallen
All Listed Sponsors
lead
Jochen Vehoff
OTHER
NCT02048072 - Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS | Biotech Hunter | Biotech Hunter